Office Biopsies Don't Catch All Prostate Cancers

Posted on: January 20th, 2010
by: Jennifer


Most prostate cancers are detected with a standard transrectal biopsy.  However, some patients’ PSA levels continue to rise, even though they had a negative office biopsy.

Fortunately, Chicago Prostate Cancer Center has developed stereotactic transperineal prostate biopsy or STPB.  This technique is able to detect 40% more cancer than the standard office procedure.  The patient is put under general anesthesia and the biopsy samples are taken through the perineum.  The advantage to this technique, is that samples can be taken systematically from all parts of the prostate.  In addition, there is no discomfort to the patient during the biopsy and it is done on an outpatient basis, so the patient can resume normal activities within a day.

Chicago Prostate Cancer Center is pleased to offer STPB to its patients. 

“Right from the first phone call I received to schedule my biopsy, I had an outstanding experience with all CPCC staff members.  Everyone was efficient, helpful and extremely friendly.  I have rarely encountered an organization like CPCC where everyone is exemplary in their service.  Thank you for an outstanding experience!”

— Joseph, Wheaton, IL

Facebooktwittergoogle_pluspinterest